185 related articles for article (PubMed ID: 30597429)
1. Association of fetal hemoglobin level with frequency of acute pain episodes in sickle cell disease (HbS-only phenotype) patients.
Jit BP; Mohanty PK; Purohit P; Das K; Patel S; Meher S; Mohanty JR; Sinha S; Behera RK; Das P
Blood Cells Mol Dis; 2019 Mar; 75():30-34. PubMed ID: 30597429
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte cAMP in Determining Frequency of Acute Pain Episodes in Sickle Cell Disease Patients from Odisha State, India.
Jit BP; Mohanty PK; Pradhan A; Purohit P; Das K; Patel S; Meher S; Sinha S; Mohanty JR; Behera RK; Das P
Hemoglobin; 2019 Mar; 43(2):88-94. PubMed ID: 31290363
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.
Marcus SJ; Kinney TR; Schultz WH; O'Branski EE; Ware RE
Am J Hematol; 1997 Jan; 54(1):40-6. PubMed ID: 8980259
[TBL] [Abstract][Full Text] [Related]
4. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.
Patel DK; Purohit P; Dehury S; Das P; Dutta A; Meher S; Patel S; Bag S; Mashon RS; Das K
Int J Lab Hematol; 2014 Aug; 36(4):444-50. PubMed ID: 24245819
[TBL] [Abstract][Full Text] [Related]
5. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
[TBL] [Abstract][Full Text] [Related]
6. Sickle Cell Disease: Reappraisal of the Role of Foetal Haemoglobin Levels in the Frequency of Vaso-Occlusive Crisis.
Antwi-Boasiako C; Frimpong E; Ababio GK; Dzudzor B; Ekem I; Gyan B; Sodzi-Tettey NA; Antwi DA
Ghana Med J; 2015 Jun; 49(2):102-6. PubMed ID: 26339094
[TBL] [Abstract][Full Text] [Related]
7. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.
Maier-Redelsperger M; Noguchi CT; de Montalembert M; Rodgers GP; Schechter AN; Gourbil A; Blanchard D; Jais JP; Ducrocq R; Peltier JY
Blood; 1994 Nov; 84(9):3182-8. PubMed ID: 7524767
[TBL] [Abstract][Full Text] [Related]
8. Clinical variability and molecular characterization of Hbs/Gγ (Aγδβ)0-thal and Hbs/HPFH in Indian sickle cell disease patients: AIIMS experience.
Pandey H; Singh K; Ranjan R; Pandey SK; Sharma A; Kishor K; Seth T; Mahapatra M; Saxena R
Hematology; 2019 Dec; 24(1):349-352. PubMed ID: 30777489
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of clinical severity through raised fetal hemoglobin in sickle cell anaemia.
Ponnazhagan S; Sarkar R
Indian J Pediatr; 1992; 59(1):85-90. PubMed ID: 1377179
[TBL] [Abstract][Full Text] [Related]
10. HbF-promoting polymorphisms may specifically reduce the residual risk of cerebral vasculopathy in SCA children with alpha-thalassemia.
Joly P; Bonello-Palot N; Badens C; Pissard S; Chamouine A; Bernaudin F; Bertrand Y; Connes P; Renoux C
Clin Hemorheol Microcirc; 2021; 77(3):267-272. PubMed ID: 33216016
[TBL] [Abstract][Full Text] [Related]
11. alpha-Thalassemia and HbF concentration in sickle cell anemia.
Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
[No Abstract] [Full Text] [Related]
12. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
[TBL] [Abstract][Full Text] [Related]
13. Pain in sickle cell disease. Rates and risk factors.
Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
[TBL] [Abstract][Full Text] [Related]
14. The influence of fetal hemoglobin on the clinical expression of sickle cell anemia.
Powars DR; Chan L; Schroeder WA
Ann N Y Acad Sci; 1989; 565():262-78. PubMed ID: 2476064
[TBL] [Abstract][Full Text] [Related]
15. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
[TBL] [Abstract][Full Text] [Related]
16. Interaction between HBS-beta-o-thalassemia and alpha-thalassemia.
Steinberg MH; Coleman MB; Adams JG; Rosenstock W
Am J Med Sci; 1984 Dec; 288(5):195-9. PubMed ID: 6083725
[TBL] [Abstract][Full Text] [Related]
17. Osteomyelitis in sickle cell haemoglobinopathy with elevated fetal haemoglobin.
Narchi H
Ann Trop Paediatr; 2000 Mar; 20(1):70-5. PubMed ID: 10824218
[TBL] [Abstract][Full Text] [Related]
18. Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil.
Figueiredo MS; Kerbauy J; Gonçalves MS; Arruda VR; Saad ST; Sonati MF; Stoming T; Costa FF
Am J Hematol; 1996 Oct; 53(2):72-6. PubMed ID: 8892730
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
20. Negative Epistasis between Sickle and Foetal Haemoglobin Suggests a Reduction in Protection against Malaria.
Mmbando BP; Mgaya J; Cox SE; Mtatiro SN; Soka D; Rwezaula S; Meda E; Msaki E; Snow RW; Jeffries N; Geller NL; Makani J
PLoS One; 2015; 10(5):e0125929. PubMed ID: 25965586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
